Skip to NavigationSkip to content

News

Boehringer Ingelheim and biotech firm OSE Immunotherapeutics have announced that they have entered an exclusive collaboration and license agreement...
New figures show that hospital admissions related to obesity have doubled over the last four years in the UK, placing an increasing strain on an NHS...
Eli Lilly and Sigilon Therapeutics have announced a partnership that looks to break new ground in the management of type 1 diabetes, by using stem...
NICE has issued draft guidance rejecting the routine use of Sanofi’s Dupixent (dupilumab) for the treatment of moderate-to-severe atopic dermatitis...
28 years after the US first pioneered proton beam therapy at Loma Linda University Medical Center, the UK now has its own centre that will be able to...
A combination of two specific drug varieties may offer an effective treatment for most kinds of lung cancer by blocking their use of the cytokine...
A surprise new name was thrown into the ring to take on Pfizer’s healthcare unit but speculation suggests that valuation is once again the sticking...
Two of Kite Pharma's former executives have burst back onto the CAR T scene by licensing Pfizer's portfolio of potential allogeneic treatments.
NHS England is trialling centres that should be able to provide rapid answers as to whether a patient has cancer or not, by taking on patients who...
Alkermes has revealed that the FDA has refused to review its major depressive disorder treatment ALKS 5461 due to concerns the company provided...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches